DatasetName,CDC42BPA_S(1025) CDC42BPA_S(1567) CDC42BPA_S(1651) CDC42BPA_S(1654) CDC42BPA_S(1656) CDC42BPA_S(1657) CDC42BPA_S(1673) CDC42BPA_S(1715) CDC42BPA_S(1719) CDC42BPA_S(1721) CDC42BPA_S(1724) CDC42BPA_S(1741) CDC42BPA_S(3) CDC42BPA_S(908) CDC42BPA_T(11) CDC42BPA_Y(1677),CDC42BPA_M(1629) CDC42BPA_S(1532) CDC42BPA_S(1545) CDC42BPA_S(1611) CDC42BPA_S(1613) CDC42BPA_S(1629) CDC42BPA_S(1633) CDC42BPA_S(1635) CDC42BPA_S(1678) CDC42BPA_S(1680) CDC42BPA_S(1691) CDC42BPA_S(1693) CDC42BPA_S(1703) CDC42BPA_S(1743) CDC42BPA_S(1746) CDC42BPA_S(6) CDC42BPA_S(678) CDC42BPA_S(940),CDC42BPA_S(1648) CDC42BPA_S(1676) CDC42BPA_S(674) CDC42BPA_T(992) CDC42BPA_T(994) CDC42BPA_Y(1341)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,0.5263623178243166,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,0.40146726846420944,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5181831784578459,0.41043974741177963,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.49871555944827584,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,0.513690522206438,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.5226212318182277,,
RB2022_5_PreEndurance,0.511963492005265,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5112169477485451,0.4128528064863464,0.6267059776007988
WZ2023_Pu_010_30min,0.521202504493336,0.40055560265878126,0.6357507364637868
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.49192465129715013,,
RB2022_8_RecoveryEndurance,0.5174440938711318,,
KBE2022_Log2_Ex_14_U,,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.5196800055791874,0.4088417747277268,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,0.516419559406711,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,0.5043879923949177,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5165406705487199,0.4049183320633029,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5437225245712427,0.4000749462580349,0.6485662493796256
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.5176111597997496,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5095226868632196,,
GF2025_P6_Sph,,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5203408654442587,0.41129495465411003,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.5204655091595901,0.4060892267730323,0.6377437298677683
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.5253552507405321,0.4091576390371057,0.6385559698656875
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.5138078277090551,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5257592973039472,0.4154754863019271,0.6334757517128787
AH2018_SILAC_MR_2_X,0.5041957982717408,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.5126140638909603,,
EJN2021_3_Rest_Basal,,0.4058011805300329,
CR2017_Ratio Replicate 1.3,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.49822693944466656,0.4105884490505874,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,0.40727405972312053,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,0.5260683636792207,0.40997711508792517,
AH2018_LFQ_1_C,0.506850872062693,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.5223106919900229,0.3998193389473698,0.6368102821802556
CK2022_11 40-1,0.5139733612762962,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,0.40632256007550493,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.5135465834474504,,0.6193096191212547
FSO2013_Ratio H/L normalized Rep2,0.5180696587766834,0.40508687348490413,
WZ2023_Pu_005_20min,0.5247090025428632,0.41120266693916663,0.6377851859625193
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.49181465368517274,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,0.528972723762203,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,0.522139168269224,,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.49450665951788875,0.40112507053085866,0.6697337212770912
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5185227569649933,0.41023774209546826,
KBE2022_Log2_Ex_8_T,,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,0.5049294718520168,0.407223294502134,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.502862173720786,,
CK2022_3 40-1,0.5155187254293816,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.5157620458054784,0.4058852437219673,
HH2022_Reporter intensity 8,,,0.6531681452296784
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.5354214396521167,0.4144585243314268,
EJN2021_5_Rest_Basal,,0.4052381823485838,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.4992524359608038,0.4109798857854283,
YA2020_Reporter_intensity_Normal_No.1,0.5228237950821486,0.40508159754659745,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.5000354507201313,0.41846504585393296,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,0.4110019617189946,
WZ2023_Pu_010_20min,0.5231340013581242,0.4009933288198286,0.6370986898932648
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.5156522956960635,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,0.4960375261517553,,0.6271863425257536
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,0.5140282663433602,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,0.40570836004867533,
FSO2013_Ratio H/M normalized Rep2,0.5001395297954334,0.41429055783542895,
RAM2015_Log2 A,,0.4082615998379421,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,0.5175046284746784,,0.622612472125407
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.4994016469732997,0.4109408123104801,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5120562557923097,0.4129499862329429,0.6270341873284392
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5228729475246756,0.4084392476212358,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.5148815341588289,,
AH2018_SILAC_IT_3_X,0.5198920991115131,0.4051743692189738,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.4864736463808305,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,0.6529312012786163
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.5147955530297359,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,0.4017262446358263,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.5082563741073064,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.5181305788154019,0.404382435950532,0.634508684658292
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.49686387133202875,0.4099592376290925,
EJN2021_4_Rest_Ins,,0.41043367527727814,
RN2012_H05,,0.41476855592617395,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,0.40901738489757616,
HH2022_Reporter intensity 3,,,0.6129129389422783
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.5221298613362562,0.4016668194752892,
JW2021_After_3,,,
GF2025_P8_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,0.40657613401650416,
CK2022_11 200-1,0.5098059174152331,,
CK2022_12 200-1,0.5088868854032684,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,0.6505746697674146
WZ2023_Su_010_20min,0.5238402480631409,0.4045547723525702,0.6356452471384145
AH2018_TMTMS2_2_N,0.5203091878016922,0.408368192126035,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5059446151436976,0.4109615092316098,
AH2018_TMTMS3_Pool,0.538258843541075,0.4129854833731399,
KS2014_Intensity N4,0.5087317786008481,,0.6311598199336389
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.5097915946562571,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.5327472551114402,0.4146004038316754,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,0.4129235493239263,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,,,
GF2025_P1_Sph,,,
EJN2021_5_Ex_Basal,,0.40925281290943066,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5177594940313197,0.4040291372441456,0.6393993366398477
CF2017_EOC 1,,0.40396639244907706,
CK2022_3 200-1,0.5229406728016384,,
AH2018_LFQ_IT_3_C,,0.40277188563318295,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.5160481365925775,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.5221915076094611,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,0.5172726424708001,0.4018345968411977,0.6478695397954133
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,0.4081497641437241,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.5100567201631286,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,0.4058306728179075,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,0.5148913944660842,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5259918200110747,0.4129349100661171,0.6344635521394653
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,0.40634020734784815,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.5371296702331536,0.4149598616866888,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,,
AH2018_LFQ_M_1_N,0.4940714298230538,,
KBE2022_Log2_Ex_27_U,,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,0.4064508842108132,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.5149932989776493,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.5130694374518062,,
YA2020_Reporter_intensity_Normal_No.4,0.5202590637168656,0.4046767251436736,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,,0.41223593667601516,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5247396808161406,0.4151160892182077,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.5137873635211888,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5399868022081106,0.41407882521188294,
HH2022_Reporter intensity 6,,,0.6578593161753578
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5112350208698978,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.5210008538073015,0.4100100171129172,
GF2025_P3_Adh,,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,0.5224703657232564,0.40872905930781456,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5060622492907921,0.41338070729930143,
KBE2022_Log2_Ex_19_U,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.5233267817364864,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.5094597935816526,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5175573391244846,,
RB2022_7_RecoverySprint,0.5190612960409985,,
YA2020_Reporter_intensity_Normal_No.3,0.5247419247253108,0.4033164280518095,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.5024545867054725,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.48630604257257204,,0.6319399664512448
HH2022_Reporter intensity 1,,,0.6133791811746915
HH2022_Reporter intensity 2,,,0.6111042909748924
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.5185564457649455,0.40239695759494193,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5160872695259314,0.41588015424607944,0.6148708504225204
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.5292426736730518,0.4096561250160308,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.5227192110632759,0.4177014186740904,
AR2021_KD 72h,0.5118592720986828,0.416787089777141,0.6375402861265869
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.5373582072076986,0.41337310743828826,
KBE2022_Log2_Ex_9_U,,,
AH2018_SILAC_M_3_N,0.5002387142179346,0.4113114655569645,
KBE2022_Log2_Ex_13_T,,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,,
RN2012_L12,0.5231347004847077,0.4109580128717179,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.49567528475571504,0.40903434511903175,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5252491638835743,0.4168870439618551,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5148083192643922,,
RB2022_7_RecoveryEndurance,0.5176287551963039,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,0.4060819361704203,
TM2022_S2.12h.B,,,
RN2012_L15,0.5127365530074458,0.4060593925765925,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,0.40307922012490016,
FSO2013_Ratio H/M normalized Rep2___2,0.4930720752488897,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.5236075125629109,,0.6120469878827673
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.517377248949131,,
CK2022_5 200-1,0.5177358830543213,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.5181916135906799,0.4051330870069314,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,0.5014610664145216,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,0.4957297056489248,0.4090398684025848,
EJN2021_5_Rest_Ins,,0.4091073898970238,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5009073606645053,0.4163450480147709,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,0.4113125408130015,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.5178354409207858,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.5116166170916401,0.4052261833937148,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,,,
AH2018_SILAC_IT_2_N,0.49593090774267107,0.4094993291727817,
AH2018_SILAC_IT_1_X,0.5197566811684106,0.40130483725717375,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,
WZ2023_Pe_025_20min,0.5226891244023535,0.40456443941103015,0.6387629658802568
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.48372783265683483,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.5219210609383199,0.4098163509762476,
RN2012_H06,0.5086653740077621,0.4054429815466148,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.5263864008906829,0.4156972764603597,0.6364760653905343
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5196220324864577,0.4172019676106151,
WZ2023_Su_025_10min,0.5265194519689124,0.4122409706908708,0.6374914730454365
AH2018_LFQ_IT_4_X,0.4981904433883771,0.41057533809770325,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.528062585032757,0.4171425513671146,0.6355178609624236
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,0.5151087419961924,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5595716120307238,0.4050707944355845,0.6506649006873959
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.5101864646669884,,0.6363873067849692
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,0.5256697011517195,,
EP2017_Untreated R#1 normalized log2 ratio,0.5318871996912296,0.4125623467778115,0.625399293165823
RN2012_L10,0.5153728441856877,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,0.49025950015326647,0.4023267654906584,0.667847679815213
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.5198243495594561,0.40484010129623044,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5471776434472178,0.4127071783140614,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5106413852939539,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.49177301545871355,0.40133979636355666,0.6262107064594294
GF2025_P9_Sph,,,
CK2022_6 200-1,0.5169102445012779,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.5391852407048379,0.4094350848278178,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.5293668694301743,0.41157233476607114,0.6370894247473324
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5171136127892094,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,0.5101128577013929,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5520695325145826,0.402401184239577,0.6395247006861969
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,0.40281165902574856,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,0.40748952010999145,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.498564747305635,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,0.4087922888260934,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,0.4004499708965857,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,0.5304413318071209,0.4116794099195123,0.637446143457793
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,0.40861587638667757,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,,
YA2020_Reporter_intensity_Normal_No.2,0.5189089587713409,0.40706062422615447,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.4876425453043837,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,,
CK2022_2 16-1,,,
RAM2015_Log2 B,,0.4083639915172479,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.5016119193542748,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,0.40793649719827324,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.5258629468761205,0.41317026323192635,0.636784503713246
AH2018_LFQ_4_N,0.4994228064465497,,
CR2017_Ratio Replicate 1.2,,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,0.6569325702143624
AH2018_SILAC_M_1_X,,0.4068914186259587,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,0.5135498554101827,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.5430107606509962,0.4122880778538027,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,0.515274771098487,,
KS2014_Intensity C5,0.5256484432548303,,0.6440122335730031
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.5070601615387837,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,0.5192423244008335,,0.6220478809708879
GF2025_P3_Sph,,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,0.40144001127353346,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.4920516801885262,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5163448391596396,0.40591686566533947,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.4936459986509684,0.4081011191268183,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,,,
LY2019_P6-,0.5256100136924206,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5146766727626041,0.4151114057919336,
AH2018_LFQ_3_N,0.505003125545024,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.5164880653175012,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.5150123868709908,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,0.40159579869625683,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.525864773051246,0.4113338935398452,0.6371089204009759
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5128834986268115,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.5255051445514575,0.40908373607678983,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.5141143023588778,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.5167383564559858,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,0.5208983509942199,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,0.406693957145701,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,0.4065450036997082,
EP2017_Pervanadate R#3 log2 ratio,0.5452647196117528,0.4003162141352125,0.648813613345563
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,0.5071143831982728,,
AH2018_LFQ_M_4_C,0.5124796029431808,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,0.40509476562869184,
CK2022_6 40-1,0.5148466366386754,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,0.5482444482647287,0.41850539691042477,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,0.41116560406887764,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5184723961932438,0.3990141433136271,0.6383164342176743
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,0.40631255329091354,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,0.413183373708122,
WZ2023_Pu_025_20min,0.5214803372026648,0.40098465672259287,0.6343773632833499
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5214709339064442,0.40803862309635286,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.5375875896271518,0.41457651958110214,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,0.4032508757853136,
LY2019_P8+,0.4981616924862449,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5128452162621814,0.4101461444653633,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.5113858921310396,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,0.522131418986604,0.4144624283371877,
AH2018_LFQ_IT_1_X,,0.406252483308403,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.5157903178137987,,
WZ2023_Pe_005_20min,0.5194954687497085,0.4001425605558793,0.6388715284190176
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5158692966231767,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,,
AH2018_TMTMS3_3_N,0.5357392725641587,0.41605277104521304,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.5098639051773112,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.4901133896377236,0.40253417967120986,0.6663657985314142
KBE2022_Log2_Ex_36_T,,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5255970436980255,0.41173610142004446,0.6376801567432144
KS2014_Intensity C2,0.5144653033249609,0.40875167905368226,0.637590361729529
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,0.5099474878797582,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5105117689823131,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5183140694437189,0.4057976340800612,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.5206483010436497,,0.6253978872292573
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,0.40841524559474657,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,0.5230195074191375,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5328142835078309,0.412670936233406,0.6257183028799261
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.5190461196659264,0.4037499515422751,0.6351968709531218
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,0.4987827606571579,,0.6516886086598928
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.553900283887658,0.4107204500468752,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.5017560150344377,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.5040614834164622,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.5086992970451466,0.41289390441682516,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.5044904353762202,0.4136172133959777,0.6321558580271777
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5232154767113033,0.39987648734023334,0.6371638761377084
KBE2022_Log2_Ex_29_U,,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.5053371377094927,,
AH2018_LFQ_IT_4_N,0.49923486956180313,0.41098667626037755,
CK2022_15 200-1,0.5097448273143439,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.525417417574559,0.40557943716849254,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.5222752354956939,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5223859909455776,0.4044270422185152,0.6357623113203985
RN2012_H01,0.4990155622335356,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,0.41068837610217174,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5584503858669625,0.40485541270166675,0.6503295213316889
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.5155690471338582,0.4044636679523805,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.5214834953654444,0.4014521471432946,0.6383125353288276
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.5134531055506436,0.4079686866525393,0.6408571380221731
FSO2013_Ratio H/M normalized Rep3___1,0.5131987779427731,0.4177265524640934,
AH2018_SILAC_M_3_C,0.4971289918614336,0.40947505932365286,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,0.40341988703973325,
AH2018_SILAC_M_2_X,,0.4064413282800077,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5250470220923439,0.41027344885746886,0.6355819983519851
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.5018440310181956,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.5215420942834599,0.41038812800597113,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,0.507418394484073,0.4151448679201905,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5200350768151435,0.40610021140442654,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.48859838678548734,0.40120902859447205,0.6251189282557912
EJN2021_2_Ex_Basal,,0.4073616032558033,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,0.4092223480892023,
AR2021_L41 10 μM,0.5090949242062183,0.4155397776551431,0.6312676583563844
CF2017_EOC 2,,0.40741594600386183,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,0.4057054611361117,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,0.5173294107638735,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,0.5191798498043899,0.4095913412282196,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,,0.613433147366905
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.521628063822207,0.40988420328360275,
AR2021_L41 1 μM,0.5043176212711219,0.4181229016884268,0.6320443288227587
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.519823394583706,0.4093000664150966,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5187174438980323,0.4094526227415661,
KS2014_Intensity C4,0.5182486120039589,,0.6460802205766399
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.48445822656532894,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.5169142538616951,0.4042924910913634,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.5133488563008816,,
AH2018_SILAC_IT_3_C,0.5221133944378578,0.4051020338019995,
WZ2023_Pu_025_10min,0.520261455006825,0.40226724740611264,0.6366186189740614
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.5141400715347568,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,0.41355604857984596,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5217747567450471,0.404769093376643,0.639340973703303
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,0.40658386814615555,
KS2014_Intensity C6,0.5096254865145872,0.4082180213265633,0.6387725815975628
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5141401409740057,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5187764499754217,0.4113843787989989,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.5144343256504121,,
AH2018_SILAC_IT_2_C,0.5221048792770847,0.40552306029621576,
CK2022_5 40-1,0.5149779348726089,,
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,
LY2019_P7-,0.5438202437203534,,
GF2025_P5_Adh,,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.5117426817918842,0.40532105228771853,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.5117388648103257,0.4153930939166679,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.5075585563873919,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.5031753271005339,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,0.5148094906623598,0.4023956988568833,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,0.4929936038865288,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.4917021036308748,0.4010312399857958,0.6679378025996187
AH2018_TMTMS2_1_X,0.5219652546646831,0.4096320050666843,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,0.4063291367747152,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,0.6466278495015159
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,0.40692375011748916,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,0.4062648042544019,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,0.5351321291983893,0.4126903147711379,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,0.402083321590257,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,,
EP2017_Untreated R#2 normalized log2 ratio,0.5153589496580089,0.4157659042100149,0.6147276272025755
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5194972594189243,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5538362684718677,0.40265707219189467,0.6400043614205894
AS2011_Ratio H/L Normalized RNAi_2_1,,,
